We are live on ! Find out more
NVCHI

New Vernon Capital Holdings II Portfolio holdings

AUM $136M
1-Year Est. Return 29.35%
This Fund
S&P 500
This Quarter Est. Return
-6.24%
1 Year Est. Return
+29.35%
3 Year Est. Return
+78.2%
5 Year Est. Return
+87.75%
10 Year Est. Return
+286.47%
AUM
$64.7M
AUM Growth
-$31.7M
Cap. Flow
-$24.3M
Cap. Flow %
-37.53%
Top 10 Hldgs %
82.45%
Holding
53
New
6
Increased
22
Reduced
5
Closed
13

Sector Composition

Rank Sector Weight
1 Financials 17.83%
2 Healthcare 6.48%
3 Communication Services 3.96%
4 Technology 2.65%
5 Consumer Discretionary 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
26
CVS Health
CVS
$119B
$329K 0.51%
5,020
GILD icon
27
Gilead Sciences
GILD
$169B
$317K 0.49%
5,071
+1,349
+36% +$94.3K
HPQ icon
28
HP
HPQ
$26.6B
$308K 0.48%
15,058
+4,139
+38% +$96.5K
ALSN icon
29
Allison Transmission
ALSN
$10.3B
$272K 0.42%
6,204
+2,015
+48% +$93.4K
AMGN icon
30
Amgen
AMGN
$223B
$265K 0.41%
1,360
IPG
31
DELISTED
Interpublic Group of Companies
IPG
$264K 0.41%
+12,774
New +$292K
JNPR
32
DELISTED
Juniper Networks
JNPR
$261K 0.4%
9,702
DNB
33
DELISTED
Dun & Bradstreet
DNB
$250K 0.39%
1,754
+269
+18% +$38.4K
DLX icon
34
Deluxe
DLX
$1.11B
$246K 0.38%
6,397
+1,987
+45% +$94.8K
TVTY
35
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$241K 0.37%
9,729
+3,030
+45% +$101K
AEIS icon
36
Advanced Energy
AEIS
$12.9B
$221K 0.34%
+5,149
New +$229K
BIIB icon
37
Biogen
BIIB
$30.3B
$221K 0.34%
733
+151
+26% +$48.2K
FFIV icon
38
F5
FFIV
$23.5B
$209K 0.32%
1,292
LRCX icon
39
Lam Research
LRCX
$389B
$203K 0.31%
+14,910
New +$214K
WBD icon
40
Warner Bros
WBD
$67.9B
$200K 0.31%
8,104
BBY icon
41
Best Buy
BBY
$17.6B
-4,981
Closed -$395K
BKE icon
42
Buckle
BKE
$2.37B
-15,488
Closed -$357K
CRUS icon
43
Cirrus Logic
CRUS
$6.07B
-5,312
Closed -$205K
CSCO icon
44
Cisco
CSCO
$475B
-4,480
Closed -$218K
EWJ icon
45
iShares MSCI Japan ETF
EWJ
$22.7B
-8,008
Closed -$482K
EZU icon
46
iShare MSCI Eurozone ETF
EZU
$9.9B
-33,475
Closed -$1.37M
GME icon
47
GameStop
GME
$8.44B
-54,652
Closed -$209K
INFY icon
48
Infosys
INFY
$51B
-496,778
Closed -$5.05M
EGRX
49
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-2,918
Closed -$202K
EGOV
50
DELISTED
NIC Inc
EGOV
-16,786
Closed -$248K

Similar funds

New Vernon Capital Holdings II's Q4 2018 Portfolio in Review

As of Q4 2018, New Vernon Capital Holdings II held 53 positions worth $64.7M, down 33% from $96.4M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

New Vernon Capital Holdings II withdrew a net $24.3M in Q4 2018, closing 13 positions and reducing 5 holdings. Its most notable exit was Infosys, an estimated $5.05M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 7.8% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, New Vernon Capital Holdings II opened a new position in Dr. Reddy's Laboratories worth $2M.

  • New Vernon Capital Holdings II's largest Q4 2018 buy was Dr. Reddy's Laboratories: 265,250 shares worth $2M.
  • New Vernon Capital Holdings II added most to ICICI Bank in Q4 2018, an estimated $4.84M increase.
  • New Vernon Capital Holdings II's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $13.1M.
  • New Vernon Capital Holdings II fully exited Infosys in Q4 2018, selling an estimated $5.05M.
  • New Vernon Capital Holdings II's ten largest holdings make up 82% of its $64.7M portfolio in Q4 2018.
  • New Vernon Capital Holdings II opened 6 new positions and closed 13 in Q4 2018.
  • New Vernon Capital Holdings II's portfolio value fell 33% quarter-over-quarter to $64.7M.

Based on New Vernon Capital Holdings II's 13F filing for Q4 2018, filed 13 Feb 2019.